Cargando…

A case–control study investigating food addiction in Parkinson patients

Eating disorders (EDs) in patients with Parkinson’s disease (PD) are mainly described through impulse control disorders but represent one end of the spectrum of food addiction (FA). Although not formally recognized by DSM-5, FA is well described in the literature on animal models and humans, but dat...

Descripción completa

Detalles Bibliográficos
Autores principales: de Chazeron, Ingrid, Durif, F., Lambert, C., Chereau-Boudet, I., Fantini, M. L., Marques, A., Derost, P., Debilly, B., Brousse, G., Boirie, Y., Llorca, P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149641/
https://www.ncbi.nlm.nih.gov/pubmed/34035366
http://dx.doi.org/10.1038/s41598-021-90266-8
_version_ 1783697989377720320
author de Chazeron, Ingrid
Durif, F.
Lambert, C.
Chereau-Boudet, I.
Fantini, M. L.
Marques, A.
Derost, P.
Debilly, B.
Brousse, G.
Boirie, Y.
Llorca, P. M.
author_facet de Chazeron, Ingrid
Durif, F.
Lambert, C.
Chereau-Boudet, I.
Fantini, M. L.
Marques, A.
Derost, P.
Debilly, B.
Brousse, G.
Boirie, Y.
Llorca, P. M.
author_sort de Chazeron, Ingrid
collection PubMed
description Eating disorders (EDs) in patients with Parkinson’s disease (PD) are mainly described through impulse control disorders but represent one end of the spectrum of food addiction (FA). Although not formally recognized by DSM-5, FA is well described in the literature on animal models and humans, but data on prevalence and risk factors compared with healthy controls (HCs) are lacking. We conducted a cross-sectional study including 200 patients with PD and 200 age- and gender-matched HCs. Characteristics including clinical data (features of PD/current medication) were collected. FA was rated using DSM-5 criteria and the Questionnaire on Eating and Weight Patterns-Revised (QEWP-R). Patients with PD had more EDs compared to HCs (27.0% vs. 13.0%, respectively, p < 0.001). They mainly had FA (24.5% vs. 12.0%, p = 0.001) and night eating syndrome (7.0% vs. 2.5% p = 0.03). In PD patients, FA was associated with female gender (p = 0.04) and impulsivity (higher attentional non-planning factor) but not with the dose or class of dopaminergic therapy. Vigilance is necessary, especially for PD women and in patients with specific impulsive personality traits. Counterintuitively, agonist dopaminergic treatment should not be used as an indication for screening FA in patients with PD.
format Online
Article
Text
id pubmed-8149641
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81496412021-05-26 A case–control study investigating food addiction in Parkinson patients de Chazeron, Ingrid Durif, F. Lambert, C. Chereau-Boudet, I. Fantini, M. L. Marques, A. Derost, P. Debilly, B. Brousse, G. Boirie, Y. Llorca, P. M. Sci Rep Article Eating disorders (EDs) in patients with Parkinson’s disease (PD) are mainly described through impulse control disorders but represent one end of the spectrum of food addiction (FA). Although not formally recognized by DSM-5, FA is well described in the literature on animal models and humans, but data on prevalence and risk factors compared with healthy controls (HCs) are lacking. We conducted a cross-sectional study including 200 patients with PD and 200 age- and gender-matched HCs. Characteristics including clinical data (features of PD/current medication) were collected. FA was rated using DSM-5 criteria and the Questionnaire on Eating and Weight Patterns-Revised (QEWP-R). Patients with PD had more EDs compared to HCs (27.0% vs. 13.0%, respectively, p < 0.001). They mainly had FA (24.5% vs. 12.0%, p = 0.001) and night eating syndrome (7.0% vs. 2.5% p = 0.03). In PD patients, FA was associated with female gender (p = 0.04) and impulsivity (higher attentional non-planning factor) but not with the dose or class of dopaminergic therapy. Vigilance is necessary, especially for PD women and in patients with specific impulsive personality traits. Counterintuitively, agonist dopaminergic treatment should not be used as an indication for screening FA in patients with PD. Nature Publishing Group UK 2021-05-25 /pmc/articles/PMC8149641/ /pubmed/34035366 http://dx.doi.org/10.1038/s41598-021-90266-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
de Chazeron, Ingrid
Durif, F.
Lambert, C.
Chereau-Boudet, I.
Fantini, M. L.
Marques, A.
Derost, P.
Debilly, B.
Brousse, G.
Boirie, Y.
Llorca, P. M.
A case–control study investigating food addiction in Parkinson patients
title A case–control study investigating food addiction in Parkinson patients
title_full A case–control study investigating food addiction in Parkinson patients
title_fullStr A case–control study investigating food addiction in Parkinson patients
title_full_unstemmed A case–control study investigating food addiction in Parkinson patients
title_short A case–control study investigating food addiction in Parkinson patients
title_sort case–control study investigating food addiction in parkinson patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149641/
https://www.ncbi.nlm.nih.gov/pubmed/34035366
http://dx.doi.org/10.1038/s41598-021-90266-8
work_keys_str_mv AT dechazeroningrid acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT duriff acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT lambertc acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT chereauboudeti acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT fantiniml acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT marquesa acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT derostp acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT debillyb acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT brousseg acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT boiriey acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT llorcapm acasecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT dechazeroningrid casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT duriff casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT lambertc casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT chereauboudeti casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT fantiniml casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT marquesa casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT derostp casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT debillyb casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT brousseg casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT boiriey casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients
AT llorcapm casecontrolstudyinvestigatingfoodaddictioninparkinsonpatients